Brought to you by 
Respicardia brings in $33mm through its Series D round
27 Apr 2021
Executive Summary
Respicardia Inc. (formerly Cardiac Concepts) raised $33mm through its Series D venture round from 13 undisclosed investors. The company has developed the remede neurostimulation system to treat sleep apnea, thereby improving the health of congestive heart failure patients.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Respicardia brings in $33mm through its Series D round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice